John Kealy
Company: Ulysses Neuroscience
Job title: Chief Scientific Officer
Seminars:
Live Q&A Session with Your Expert Speakers 12:20 pm
day: Day One
Preclinical Models of Fragile X Syndrome and CDKL5 Deficiency Disorder: Learning from Patients 10:50 am
How can we get more from preclinical models by listening to patients and their families? Translational composite biomarkers are key: fluid biomarkers, neurophysiology, and naturalistic behaviours How do we rethink the mouse models for FXS and CDD? How can we improve our ways of doing translational research?Read more
day: Day One